Type 1 diabetes mellitus (T1DM) is a chronic autoimmune disease in which the body’s immune system attacks and destroys the beta cells of the pancreas, which are responsible for producing insulin. This leads to absolute insulin deficiency, which requires lifelong insulin therapy. One of the promising areas of treatment for T1DM is the use of stem cells.
READ MORE ABOUT NEW PROTOCOL 2026: Stem Cells for Diabetes Type 1 – REGENERATIVE APPROACH
Stem Cells: Basics
Stem cells have the ability to self-renew and differentiate into different types of cells. There are several types of stem cells that can be used in medicine:
Embryonic stem cells (ESCs) – have the greatest potential for differentiation, but their use is associated with ethical issues.
Induced pluripotent stem cells (iPSCs) are adult cells that have been reprogrammed to an early stage of development. They can be used to create pancreatic beta cells.
Mesenchymal stem cells (MSCs) — have anti-inflammatory and immunomodulatory properties, which makes them interesting for the treatment of autoimmune diseases.
Mechanisms of stem cell treatment
The use of stem cells in the treatment of T1D can occur in two main directions:
Regeneration of beta cells:
Pancreatic B cells, also known as beta cells, play a key role in regulating blood sugar levels. They are located in the islets of Langerhans, the endocrine part of the pancreas, and perform the following functions:
1.Insulin Secretion
The main function of beta cells is to produce and secrete insulin, a hormone that helps maintain normal blood glucose levels. Insulin regulates the metabolism of carbohydrates, fats, and proteins by stimulating the uptake of glucose into the body’s cells. Specifically, insulin:
Promotes the uptake of glucose into muscle and fat cells.
Stimulates the liver to convert glucose into glycogen for storage.
Lowers blood glucose levels, preventing hyperglycemia.
2. Response to Changes in Glucose Levels
Beta cells are sensitive to changes in blood sugar levels. When blood glucose levels rise (such as after a meal), beta cells are activated and secrete insulin. Insulin lowers blood glucose levels by helping the body’s cells use it for energy.
3. Secretion of Other Hormones
In addition to insulin, beta cells can secrete small amounts of amylin, a hormone that complements the action of insulin. Amylin slows the absorption of glucose from the intestine, suppresses the secretion of glucagon (a hormone that increases blood sugar levels) and creates a feeling of satiety.
4. Maintaining homeostasis
Beta cells play a key role in maintaining the body’s energy balance. They respond not only to glucose levels, but also to other signals, such as amino acids and hormones, regulating metabolism and metabolism.
READ MORE: NEW therapy for Diabetes 1 type
Beta cell dysfunction
In type 1 diabetes, the immune system mistakenly attacks and destroys beta cells, which leads to insulin deficiency and the need for insulin therapy. In type 2 diabetes, beta cells can lose their ability to adequately respond to changes in glucose levels due to insulin resistance and chronic stress.
Beta cells in the pancreas play a vital role in regulating blood sugar levels and maintaining the body’s metabolic balance. Disruption of their function is the main mechanism for the development of diabetes.
One method of treatment is an attempt to restore beta cells capable of independently producing insulin. This is done using induced pluripotent stem cells (iPSCs), which are reprogrammed to differentiate into beta cells. These cells can be transplanted into the patient’s body, where they will produce insulin in response to blood glucose levels.
Immunomodulation:
Immunomodulation is an important aspect of therapy for patients with diabetes, especially type 1, for a number of reasons. The main goal of this approach is to modify or suppress the autoimmune response, which plays a key role in the development of type 1 diabetes.
Why immunomodulation is important for patients with diabetes:
1. The nature of type 1 diabetes
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the beta cells of the pancreas, which produce insulin. Without insulin, the body cannot regulate blood glucose levels, requiring constant insulin administration from outside.
Immunomodulation can help prevent the destruction of remaining beta cells in the early stages of the disease and even preserve the function of these cells if therapy is started at the initial stage of the disease.
2. Reducing the autoimmune response
The main goal of immunomodulatory therapy is to reduce the aggression of the immune system against the body’s own cells. This is important for slowing down or stopping the progression of the disease. With successful immunomodulation, residual beta cell function can be preserved, which reduces the need for insulin therapy and improves blood glucose control.
3. Prevention of complications
With prolonged destruction of beta cells without blood sugar control, diabetes leads to the development of serious complications: damage to the kidneys (nephropathy), blood vessels (angiopathy), nerves (neuropathy), and eyes (retinopathy). Immunomodulation can help prevent further damage to the pancreas, thereby reducing the risk of long-term complications.
4. Potential for remission
Some immunomodulatory drugs and methods can help not only slow down the process of beta cell destruction, but also lead to temporary remission of the disease. This is especially important in the early stages of type 1 diabetes, when some beta cells are still functioning. Maintaining their activity with the help of immunomodulation can significantly alleviate the course of the disease.
DISCOVER OUR CASE STUDY :Diabetes Type 1 Stem Cells Therapy : Case Study
5. Immunomodulation and stem cell transplantation
When stem cells are transplanted (for example, to restore beta cells), there is a risk that the immune system will reject the new cells or continue to attack them, as well as the body’s own beta cells. Immunomodulation helps reduce the risk of rejection and improve the survival of the transplanted cells.
Immunomodulatory methods
A variety of immunomodulatory methods are currently being studied for the treatment of type 1 diabetes, including:
Monoclonal antibodies: These can affect the T cells of the immune system, preventing them from attacking beta cells.
Interferons and cytokines: These substances modulate inflammatory processes in the body.
Mesenchymal stem cells: Can suppress the activity of autoimmune reactions and stimulate the restoration of damaged tissues.
Conclusion
Immunomodulation plays a key role in the treatment of type 1 diabetes, as it can slow the destruction of beta cells, preserve their function, reduce the risk of complications and even potentially prolong remission of the disease. The use of immunomodulatory methods is becoming an important step towards improving the quality of life of patients with diabetes and reducing dependence on insulin therapy.
Stem cells can influence the patient’s immune system by suppressing the autoimmune process that leads to the destruction of beta cells. Mesenchymal stem cells (MSCs) have the ability to suppress inflammation and correct the immune response, which can prevent further destruction of beta cells.
Current research and clinical trials
Today, research on the use of stem cells for the treatment of T1D is in an active stage. There are several areas of clinical trials:
Reprogramming and transplantation of beta cells: Studies show that induced pluripotent stem cells can be differentiated into insulin-producing cells, but the problem is protecting these cells from further attacks by the immune system.
Immunomodulatory therapy: The use of mesenchymal stem cells is being studied as a way to reduce the activity of the autoimmune process. Clinical trials show that administering these cells can slow the progression of T1D in newly diagnosed patients.
Advantages
Advantages of stem cells in the treatment of T1D include:
The ability to restore one’s own insulin secretion.
Reduced dependence on insulin drugs.
Potential for long-term control of blood glucose levels.
Prospects
The use of stem cells opens up new horizons in the treatment of T1D, but for their widespread implementation, several key issues need to be addressed, such as the immune compatibility of transplants and the duration of the effect. Current research gives hope that in the future, stem cells will be able to become the main method of therapy, replacing or complementing insulin therapy.
Treatment of type 1 diabetes using stem cells is one of the most promising areas of medical research. Although this method has not yet become widespread, the progress achieved and clinical trials conducted give reason to hope that in the future such technologies will be able to radically change the approach to the treatment of this disease.
FREE MEDICAL CONSULTATION
